Hirschsprung Disease: Inheritance Patterns and Maternal Drug Associations
Inheritance Patterns
Hirschsprung disease (HSCR) follows complex inheritance with a high de novo mutation rate, autosomal dominant transmission with incomplete penetrance, and rare X-linked or autosomal recessive patterns. The majority of cases arise from new mutations rather than inherited ones.
De Novo Inheritance
The de novo mutation rate in HSCR is substantial. Unlike MEN2A/2B where RET mutations arise almost exclusively from paternal chromosomes, de novo RET mutations in Hirschsprung disease arise from both paternal and maternal chromosomes equally 1. This represents a fundamental biological difference between RET mutations causing HSCR versus those causing thyroid cancer syndromes.
Familial Recurrence Patterns
Among 4,331 index HSCR cases, familial recurrence occurs in 7.6% overall, but rises dramatically to 20% in total colonic aganglionosis 2. When HSCR recurs within families:
- 62% occurs in siblings
- 22% between parent and offspring
- 16% in other relatives
- 15% affects multiple generations 2
Genetic Mechanisms
The inheritance pattern depends on mutation type and penetrance:
High-penetrance RET coding mutations (found in 45% of familial cases) show:
- Autosomal dominant inheritance with incomplete penetrance 3, 4
- Higher maternal transmission asymmetry in affected sib-pairs, likely due to differential reproductive rates between male and female carriers rather than parent-of-origin effects 5
- The 20/24 and 20/25 PHOX2B genotypes may be inherited from asymptomatic parents 4
Other inheritance patterns include:
- Autosomal dominant transmission (documented in specific kindreds) 6
- Probable X-linked recessive inheritance (reported in select families) 6
- Multifactorial sex-modified inheritance in most sporadic cases
Compound Inheritance
Recent evidence demonstrates that compound inheritance of rare RET coding variants plus common high-risk RET enhancer variants (rs2506030, rs7069590, rs2435357) significantly modifies disease penetrance 7. Carriers of pathogenic RET variants without the high-risk GTT haplotype may remain asymptomatic, explaining variable expressivity within families.
Maternal Risk Factors and Drug Associations
Established Maternal Risk Factors
Maternal obesity is the only confirmed maternal risk factor, increasing HSCR risk by 74% (OR 1.74; 95% CI 1.25-2.44) 8. Children with HSCR are also born at earlier gestational ages (OR 1.60; 95% CI 1.18-2.17) 8.
Maternal Drug Use
No evidence exists linking maternal drug use to Hirschsprung disease or Hirschsprung-like disease in the fetus. The provided evidence does not identify any medications associated with HSCR development.
The only drug-related finding pertains to acetaminophen and neurobehavioral outcomes (not HSCR), where evidence remains inconclusive 9. No teratogenic medications have been documented to cause aganglionosis or HSCR-like phenotypes.
Clinical Implications for Genetic Counseling
Recurrence Risk Assessment
For families with an affected child:
If parents test negative for RET mutations:
- Germline mosaicism cannot be excluded
- Prenatal testing should be offered for subsequent pregnancies 4
- De novo mutation is most likely
If a parent carries a RET mutation:
- 50% transmission risk to each offspring 4
- Penetrance varies by specific mutation
- Cascade testing recommended for at-risk family members
For total colonic aganglionosis:
- Genetic counseling is mandatory given 20% familial recurrence 2
- Consider preimplantation genetic testing for families with identified mutations 7
Testing Recommendations
When HSCR is diagnosed:
- Test both parents for RET mutations to identify mosaicism or carrier states 4
- Genotype common RET enhancer variants (rs2506030, rs7069590, rs2435357) to assess compound inheritance 7
- Consider chromosomal microarray and whole-genome sequencing for complex cases 7
Associated Conditions
34.5% of HSCR cases have associated malformations 8. Specific associations include:
- MEN2A with cutaneous lichen amyloidosis or Hirschsprung disease 3
- Renal agenesis (documented with compound RET inheritance) 7
- Down syndrome and other chromosomal abnormalities 10
Critical distinction: Loss-of-function RET variants cause isolated Hirschsprung disease, while gain-of-function variants cause MEN2. Rare "Janus variants" exhibit both effects, resulting in combined MEN2 and HSCR phenotypes 11.